TY  - GEN
AU  - Moriarty,Patrick M
AU  - Roth,Eli M
AU  - Karns,Adam
AU  - Ye,Ping
AU  - Zhao,Shui-Ping
AU  - Liao,Yuhua
AU  - Capuzzi,David M
AU  - Bays,Harold E
AU  - Zhang,Fumin
AU  - Liu,Shaowen
AU  - Reichman,Alan J
AU  - Brusco,Osvaldo A
AU  - Lu,Guoping
AU  - Lerman,Sam
AU  - Duan,Zhenwen
AU  - Guo,Shuren
AU  - Liu,Ping Lan
AU  - Zhao,Junxian
AU  - Zhang,Yan
AU  - Li,Simon
TI  - Effects of Xuezhikang in patients with dyslipidemia: a multicenter, randomized, placebo-controlled study
SN  - 1933-2874
PY  - 2015///0930
KW  - Adult
KW  - Aged
KW  - Apolipoproteins A
KW  - blood
KW  - Apolipoproteins B
KW  - Biological Products
KW  - immunology
KW  - China
KW  - Cholesterol, HDL
KW  - Cholesterol, LDL
KW  - Drugs, Chinese Herbal
KW  - administration & dosage
KW  - Dyslipidemias
KW  - diagnosis
KW  - Female
KW  - Gastrointestinal Diseases
KW  - etiology
KW  - Humans
KW  - Hypolipidemic Agents
KW  - Lovastatin
KW  - therapeutic use
KW  - Male
KW  - Middle Aged
KW  - Placebos
KW  - Triglycerides
KW  - United States
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.jacl.2014.09.002
ER  -